Cumberland Pharmaceuticals Stock Analysis
| CPIX Stock | USD 4.50 0.31 6.44% |
Cumberland Pharmaceuticals is overvalued with Real Value of 4.13 and Hype Value of 4.5. The main objective of Cumberland Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Cumberland Pharmaceuticals is worth, separate from its market price. There are two main types of Cumberland Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Cumberland Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cumberland Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Cumberland Stock trading window is adjusted to America/New York timezone.
Cumberland | Build AI portfolio with Cumberland Stock |
Cumberland Stock Analysis Notes
About 44.0% of the company shares are held by company insiders. The book value of Cumberland Pharmaceuticals was currently reported as 1.64. The company recorded a loss per share of 0.46. Cumberland Pharmaceuticals last dividend was issued on the 29th of October 2010. The entity had 2:1 split on the 6th of July 2007. Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. Cumberland Pharmaceu operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 83 people. For more info on Cumberland Pharmaceuticals please contact the company at 615 255 0068 or go to https://www.cumberlandpharma.com.Cumberland Pharmaceuticals Investment Alerts
| Cumberland Pharmaceuticals is way too risky over 90 days horizon | |
| Cumberland Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 37.87 M. Net Loss for the year was (6.44 T) with profit before overhead, payroll, taxes, and interest of 31.28 M. | |
| Cumberland Pharmaceuticals currently holds about 18.22 M in cash with (612.19 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24. | |
| Roughly 44.0% of the company shares are held by company insiders |
Cumberland Pharmaceuticals Upcoming and Recent Events
Earnings reports are used by Cumberland Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Cumberland Pharmaceuticals Thematic Classifications
In addition to having Cumberland Pharmaceuticals stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery | |
 | Health ManagementHealthcare providers, hospitals |
Cumberland Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 67.19 M.Cumberland Profitablity
The company has Profit Margin (PM) of (0.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.18) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.18.Technical Drivers
As of the 4th of May, Cumberland Pharmaceuticals shows the Mean Deviation of 7.39, downside deviation of 6.47, and Risk Adjusted Performance of 0.2433. Cumberland Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cumberland Pharmaceuticals Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cumberland Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cumberland Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Cumberland Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cumberland Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cumberland Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cumberland Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cumberland Pharmaceuticals Outstanding Bonds
Cumberland Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cumberland Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cumberland bonds can be classified according to their maturity, which is the date when Cumberland Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Cumberland Pharmaceuticals Predictive Daily Indicators
Cumberland Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cumberland Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cumberland Pharmaceuticals Forecast Models
Cumberland Pharmaceuticals' time-series forecasting models are one of many Cumberland Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cumberland Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Cumberland Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cumberland Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cumberland shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cumberland Pharmaceuticals. By using and applying Cumberland Stock analysis, traders can create a robust methodology for identifying Cumberland entry and exit points for their positions.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. Cumberland Pharmaceu operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cumberland Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.